Bild von Feli, 56, ADHS-Diagnose vor 1 Jahr

SERVICE

Sie haben Fragen oder möchten weitere Informationen? Unser Team steht Ihnen gerne zur Verfügung. Rufen Sie an oder schreiben Sie uns. Wir setzen uns umgehend mit Ihnen in Verbindung. Zudem informiert unser Newsletter Sie regelmäßig über neueste Forschungsergebnisse und aktuelle Entwicklungen.

PZN: 20053263

Seitenansicht eines jungen Mannes, der auf sein Handy schaut

BLEIBEN SIE AUF DEM LAUFENDEN

Sie möchten über aktuelle Studien und wegweisende Erkenntnisse informiert werden? Dann melden Sie sich jetzt für unseren Newsletter an, um stets auf dem neusten Stand zu bleiben. Füllen Sie einfach das Kontaktformular aus und Sie werden automatisch über wichtige Updates und die Verfügbarkeit der DiGA ORIKO® informiert!

Jetzt anmelden

MATERIAL ZUM DOWNLOAD

Hier finden Sie Hilfreiches und Interessantes ganz einfach zum Herunterladen.

Allgemeine Materialien

Icon für eine Datei zum Download

Infoblatt für Behandler:innen

Herunterladen
Icon für eine Datei zum Download

Informationen zur Verordnung von ORIKO®

Herunterladen
Icon für eine Datei zum Download

Informationsbroschüre für Patient:innen

Herunterladen
Icon Download Material

Therapiemanual

Herunterladen
Icon für eine Datei zum Download

Gebrauchsanweisung

Herunterladen

Auszüge aus der App

Icon für eine Datei zum Download

Eisenhower-Matrix

Herunterladen
Icon für eine Datei zum Download

Gefühlskreis

Herunterladen
Icon für eine Datei zum Download

Verhaltensanalyse: Kreativer Zeitvertreib

Herunterladen

Regulatorische Dokumente

Icon für eine Datei zum Download

Datenschutzerklärung

Icon für eine Datei zum Download

Einwilligungserklärung

Icon für eine Datei zum Download

Nutzungsbedingungen

HIER ERHALTEN SIE EINEN TESTZUGANG

Wenn Sie als Psychiater:in, Neurolog:in, psychologische Psychotherapeut:in oder Allgemeinmediziner (mit ADHS Patienten in Behandlung) oder einem verwandten Fachbereich tätig sind, laden wir sie herzlich ein, anhand eines Testzugangs, die 3 Therapiebausteine der ADHS-DiGA ORIKO® selber auszuprobieren. Bitte beachten Sie es wird nur 1 Testzugang pro Person verteilt. Des Weiteren bitten wir Sie keinen Testzugang an Patienten weiterzugegeben.

Anrede
Ja, ich möchte mich für einen Testzugang anmelden und stimme zu, dass meine Angaben aus diesem Formular dafür erhoben und verarbeitet werden. Nähere Informationen dazu finde ich in den Datenschutzhinweisen (https://www.oriko-adhs.de/fachkreis/service/testzugang-datenschutzhinweise). Meine Einwilligung kann ich jederzeit ohne Angabe von Gründen gegenüber Takeda widerrufen.

SO ERREICHEN SIE UNS

Sie haben weitere Fragen zur Anwendung von ORIKO®? Unser Team steht Ihnen montags bis donnerstags von 8:00 bis 17:00 Uhr und Freitag von 8:00 bis 15:00 Uhr zur Verfügung.

icon_telefon_hcps

0800/295 3333

Brief-Icon

info@oriko-adhs.de

 

WIR BEANTWORTEN IHRE FRAGEN PERSÖNLICH

Sie haben Fragen oder möchten weitere Informationen? Dann schreiben Sie uns. Wir werden uns schnellstmöglich mit Ihnen in Verbindung setzen. Um Sicherheitsprobleme zu melden, verwenden Sie bitte das Formular.

Anrede
Referenzen

Ergebnisse Quellen (nur der Erstautor bzw. die Erstautorin wurde aufgeführt, weitere et al.)

Funktionalität „Digitaler ADHS-Test“

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • 2nd S3 guideline ADHD in children, adolescents and adults. DGPPN, German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP), German Society for Social Pediatrics and Adolescent Medicine e. V. (DGSPJ), 2018.

  • Attoe DE, et al. Diagnosis: A Systematic Review of ADHD in Adult Women. J Atten Disord. 2023 May;27(7):645-657.

  • Brod M, et al. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA. Atten Defic Hyperact Disord. 2015; 7: 141-50.

  • Kessler RC, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005; 35: 245-56.

  • Adler LA, et al. Validity of pilot Adult ADHD Self-Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry 2006; 18: 145-8.

  • Brevik EJ, et al. Validity and accuracy of the Adult Attention-Deficit/Hyperactivity Disorder (ADHD) Self-Report Scale (ASRS) and the Wender Utah Rating Scale (WURS) symptom checklists in discriminating between adults with and without ADHD. Brain Behav. 2020 Jun;10(6):e01605.

  • Reimherr FW, et al. Psychometric data and versions of the Wender Utah Rating Scale including the WURS-25 & WURS-45. Data Brief. 2021 Jun 17;37:107232.

  • Harrison AG, et al. The Ability of Self-Report Methods to Accurately Diagnose Attention Deficit Hyperactivity Disorder: A Systematic Review. J Atten Disord. 2023 Oct;27(12):1343-1359.

  • Taylor A, et al. Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. Res Dev Disabil. 2011 May-Jun;32(3):924-38.

Funktionalität „Suche ADHS-Spezialist:innen”

Die systematische Suche nach Behandlungsinstitutionen (Kliniken, Ambulanzen, Arztpraxen, psychologische Praxen, Medizinische Versorgungszentren) und Behandler:innen (Ärzt:innen und Psycholog:innen) mit ADHS-Expertise in Deutschland ergab 223 Institutionen oder Behandler:innen in 79 Städten. Diese Informationen werden dem Nutzer bzw. der Nutzerin durch die Aktivierung des Standorts zur Verfügung gestellt. Die Datenbank wird laufend aktualisiert.


Funktionalität „Vorbereitung Konsultation“

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • May T, et al. The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2023 Aug;57(8):1101-1116.

  • Attoe DE, et al. Diagnosis: A Systematic Review of ADHD in Adult Women. J Atten Disord. 2023 May;27(7):645-657.


Funktionalität „Digitale Therapie“

Psychotherapie

Effektivität

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • 2nd S3 guideline ADHD in children, adolescents and adults. DGPPN, German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP), German Society for Social Pediatrics and Adolescent Medicine e. V. (DGSPJ), 2018.

  • Faraone SV, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev 2021; 128: 789-818.

  • May T, et al. The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2023 Aug;57(8):1101-1116.

  • Kooij JJS, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019 Feb;56:14-34.

Kognitive Verhaltenstherapie

  • Jensen CM, et al. Cognitive behavioural therapy for ADHD in adults: systematic review and meta-analyses. Atten Defic Hyperact Disord. 2016 Mar;8(1):3-11.

  • Nimmo-Smith V, et al. Non-pharmacological interventions for adult ADHD: a systematic review. Psychol Med. 2020 Mar;50(4):529-541.

  • Liu CI, et al. Effectiveness of cognitive behavioural-based interventions for adults with attention-deficit/hyperactivity disorder extends beyond core symptoms: A meta-analysis of randomized controlled trials. Psychol Psychother. 2023 Sep;96(3):543-559.

  • Hesslinger B, et al. Psychotherapy of attention deficit hyperactivity disorder in adults–a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci. 2002 Aug;252(4):177-84.

  • Philipsen A, et al. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis. 2007 Dec;195(12):1013-9.

  • Philipsen A, et al. Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial. Atten Defic Hyperact Disord. 2010 Dec;2(4):203-12.

  • Philipsen A, et al. A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample. Atten Defic Hyperact Disord. 2014 Mar;6(1):35-47.

  • Philipsen A, et al. Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium. Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Dec;72(12):1199-210.

  • Lopez PL, et al. Cognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database Syst Rev. 2018 Mar 23;3(3):CD010840.

  • Mayer JS, et al. Cognitive mechanisms underlying depressive disorders in ADHD: A systematic review. Neurosci Biobehav Rev. 2021 Feb;121:307-345.

  • Young Z, et al. The Efficacy of Cognitive Behavioral Therapy for Adults With ADHD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Atten Disord. 2020 Apr;24(6):875-888.

  • Lam AP, et al. Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA Netw Open. 2019 May 3;2(5):e194980.

  • Hesslinger B, Philipsen A, Richter H (2004) Psychotherapie der ADHS im Erwachsenenalter. Göttingen: Hogrefe, Reihe: Therapeutische Praxis.

  • Safren SA, Perlman CA, Sprich S, Otto MW (2009) Kognitive Verhaltenstherapie der ADHS im Erwachsenenalter. (Deutsche Bearbeitung von E. Sobanski, M. Schumacher-Stien & B. Alm). Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft.

Achtsamkeitsbasierte Verhaltenstherapie

  • Oliva F, et al. The efficacy of mindfulness-based interventions in attention-deficit/hyperactivity disorder beyond core symptoms: A systematic review, meta-analysis, and meta-regression. J Affect Disord. 2021 Sep 1;292:475-486.

  • Lee CSC, et al. The Effectiveness of Mindfulness-Based Intervention in Attention on Individuals with ADHD: A Systematic Review. Hong Kong J Occup Ther. 2017 Dec;30(1):33-41.

  • Xue J, et al. A meta-analytic investigation of the impact of mindfulness-based interventions on ADHD symptoms. Medicine (Baltimore). 2019 Jun;98(23):e15957.

  • Krisanaprakornkit T, et al. Meditation therapies for attention-deficit/hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2010 Jun 16;2010(6):CD006507.

Online-Therapie

  • Elbe P, et al. Computerized cognitive interventions for adults with ADHD: A systematic review and meta-analysis. Neuropsychology. 2023 Jul;37(5):519-530.

  • Kenter RMF, et al. A self-guided internet-delivered intervention for adults with ADHD: Results from a randomized controlled trial. Internet Interv. 2023; 32: 100614.

Skills-Training

  • 2nd S3 guideline ADHD in children, adolescents and adults. DGPPN, German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP), German Society for Social Pediatrics and Adolescent Medicine e. V. (DGSPJ), 2018.

  • Halmøy A, et al. Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: a multicenter randomized controlled trial. BMC Psychiatry. 2022 Nov 28;22(1):738.

  • Nimmo-Smith V, Merwood A, Hank D, Brandling J, Greenwood R, Skinner L, Law S, Patel V, Rai D. Non-pharmacological interventions for adult ADHD: a systematic review. Psychol Med. 2020 Mar;50(4):529-541.

  • López-Pinar C, et al. Efficacy of Nonpharmacological Treatments on Comorbid Internalizing Symptoms of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. J Atten Disord. 2020 Feb;24(3):456-478.

  • Hirvikoski T, et al. Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behav Res Ther. 2011 Mar;49(3):175-85.

  • Langberg JM, et al. Organizational-skills interventions in the treatment of ADHD. Expert Rev Neurother. 2008 Oct;8(10):1549-61.

  • Cole P, et al. CBT/DBT skills training for adults with attention deficit hyperactivity disorder (ADHD). Psychiatr Danub. 2016 Sep;28(Suppl-1):103-107.

  • Carroll P, et al. Group-based emotion regulation skills training for adults with ADHD: A feasibility study in an outpatient psychiatric setting. Appl Neuropsychol Adult. 2023 Jan-Feb;30(1):71-82.

  • Oliva F, et al. The efficacy of mindfulness-based interventions in attention-deficit/hyperactivity disorder beyond core symptoms: A systematic review, meta-analysis, and meta-regression. J Affect Disord. 2021 Sep 1;292:475-486.

  • Morgensterns E, et al. Structured skills training for adults with ADHD in an outpatient psychiatric context: an open feasibility trial. Atten Defic Hyperact Disord. 2016 Jun;8(2):101-11.


Psychoedukation

(nach Themen alphabetisch geordnet)

Alltagsbeeinträchtigungen (PE-Block 1-3, 1-7, 2-1, 3-1, 4-1, 5-1, 6-1, 9-1)

  • 2nd S3 guideline ADHD in children, adolescents and adults. DGPPN, German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP), German Society for Social Pediatrics and Adolescent Medicine e. V. (DGSPJ), 2018.

  • Morellini L, et al. Social Cognition in Adult ADHD: A Systematic Review. Front Psychol. 2022 Jul 11;13:940445.

  • Weibel S, et al. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Encephale. 2020 Feb;46(1):30-40.

Arbeit (PE-Block 1-3, 7-2, 7-3)

  • 2nd S3 guideline ADHD in children, adolescents and adults. DGPPN, German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP), German Society for Social Pediatrics and Adolescent Medicine e. V. (DGSPJ), 2018.

  • Lauder K, et al. A systematic review of interventions to support adults with ADHD at work-Implications from the paucity of context-specific research for theory and practice. Front Psychol. 2022 Aug 22;13:893469.

  • Fuermaier ABM, et al. ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning. J Neural Transm (Vienna). 2021 Jul;128(7):1021-1031.

Begleiterkrankungen (PE-Block 1-3, 1-7, 3-2, 5-3, 5-4, 8-2, 8-3, 10-2, 10-3)

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • Riglin L, et al. ADHD and depression: investigating a causal explanation. Psychol Med. 2021 Aug;51(11):1890-1897.

  • Powell V, et al. ADHD in adults with recurrent depression. J Affect Disord. 2021 Dec 1;295:1153-1160.

  • Koyuncu A, et al. ADHD and Anxiety Disorder Comorbidity in Children and Adults: Diagnostic and Therapeutic Challenges. Curr Psychiatry Rep. 2022 Feb;24(2):129-140.

  • Dirks H, et al. ADHD in Adults and Comorbid Substance Use Disorder: Prevalence, Clinical Diagnostics and Integrated Therapy. Fortschr Neurol Psychiatr. 2017 Jun;85(6):336-344. German.

  • Cook J, et al. Managing attention deficit hyperactivity disorder in adults using illicit psychostimulants: A systematic review. Aust N Z J Psychiatry. 2017 Sep;51(9):876-885.

  • Wang X, et al. Attention deficits in adults with Major depressive disorder: A systematic review and meta-analysis. Asian J Psychiatr. 2020 Oct;53:102359.

  • Lai MC, Lin HY, Ameis SH. Towards equitable diagnoses for autism and attention-deficit/hyperactivity disorder across sexes and genders. Curr Opin Psychiatry. 2022 Mar 1;35(2):90-100.

  • Micai M, Fatta LM, Gila L, Caruso A, Salvitti T, Fulceri F, Ciaramella A, D’Amico R, Del Giovane C, Bertelli M, Romano G, Schünemann HJ, Scattoni ML. Prevalence of co-occurring conditions in children and adults with autism spectrum disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2023 Dec;155:105436.

  • Young S, Cocallis K. A Systematic Review of the Relationship Between Neurodiversity and Psychosexual Functioning in Individuals with Autism Spectrum Disorder (ASD) or Attention-Deficit/Hyperactivity Disorder (ADHD). Neuropsychiatr Dis Treat. 2023 Jun 2;19:1379-1395.

  • MacDonald L, et al. Management Strategies for Borderline Personality Disorder and Bipolar Disorder Comorbidities in Adults with ADHD: A Narrative Review. Brain Sci. 2023 Oct 26;13(11):1517.

  • Nazar BP, et al. The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Int J Eat Disord. 2016 Dec;49(12):1045-1057.

  • Schiweck C, et al. Comorbidity of ADHD and adult bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2021 May;124:100-123.

Emotionale Dysregulation (PE-Block 8-1)

  • Soler-Gutiérrez AM, et al. Evidence of emotion dysregulation as a core symptom of adult ADHD: A systematic review. PLoS One. 2023 Jan 6;18(1):e0280131.

  • Rüfenacht E, et al. Emotion dysregulation in adults suffering from attention deficit hyperactivity disorder (ADHD), a comparison with borderline personality disorder (BPD). Borderline Personal Disord Emot Dysregul. 2019 Jul 18;6:11.

Epidemiologie und Verlauf (PE-Block 1-3, 1-4, 1-6, 1-8)

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • Song P, et al. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health. 2021 Feb 11;11:04009.

  • Adamis D, et al. ADHD in Adults: A Systematic Review and Meta-Analysis of Prevalence Studies in Outpatient Psychiatric Clinics. J Atten Disord. 2022 Oct;26(12):1523-1534.

  • Ayano G, et al. Prevalence of attention deficit hyperactivity disorder in adults: Umbrella review of evidence generated across the globe. Psychiatry Res. 2023 Oct;328:115449.

  • GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022 Feb;9(2):137-150.

  • Harpin V, et al. Long-Term Outcomes of ADHD: A Systematic Review of Self-Esteem and Social Function. J Atten Disord. 2016 Apr;20(4):295-305.

  • Sandstrom A, et al. Prevalence of attention-deficit/hyperactivity disorder in people with mood disorders: A systematic review and meta-analysis. Acta Psychiatr Scand. 2021 May;143(5):380-391.

Erscheinungsformen (PE-Block 1-3, 1-6)

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • May T, et al. The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2023 Aug;57(8):1101-1116.

  • Salvi V, et al. ADHD in adults: clinical subtypes and associated characteristics. Riv Psichiatr. 2019 Mar-Apr;54(2):84-89. doi: 10.1708/3142.31249. PMID: 30985833.

Frauen (PE-Block 2-3, 2-4)

  • Faheem M, et al. Gender-based differences in prevalence and effects of ADHD in adults: A systematic review. Asian J Psychiatr. 2022 Sep;75:103205.

  • Kok FM, Groen Y, Fuermaier ABM, Tucha O. The female side of pharmacotherapy for ADHD-A systematic literature review. PLoS One. 2020 Sep 18;15(9):e0239257.

Lebensqualität (PE-Block 1-3, 1-7)

  • Coghill DR, et al. Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2017 Nov;26(11):1283-1307.

  • Mattos P, et al. A multicenter, open-label trial to evaluate the quality of life in adults with ADHD treated with long-acting methylphenidate (OROS MPH): Concerta Quality of Life (CONQoL) study. J Atten Disord. 2013 Jul;17(5):444-8.

  • Tanaka Y, et al. What is a clinically relevant improvement in quality of life in adults with ADHD? Journal of Attention Disorders 2019, 23: 65-75.

Mythen und Irrtümer (PE-Block 1-5, 1-9)

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • 2nd S3 guideline ADHD in children, adolescents and adults. DGPPN, German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP), German Society for Social Pediatrics and Adolescent Medicine e. V. (DGSPJ), 2018.

Nicht-pharmakologische Interventionen (PE-Block 1-3, 1-8, 3-2, 4-2, 4-3, 6-2, 6-3, 8-4, 8-5)

  • Nimmo-Smith V, et al. Non-pharmacological interventions for adult ADHD: a systematic review. Psychol Med. 2020 Mar;50(4):529-541.

  • Pagán AF, et al. Adult Attention-Deficit/Hyperactivity Disorder: a Narrative Review of Biological Mechanisms, Treatments, and Outcomes. Curr Neurol Neurosci Rep. 2023 Aug;23(8):451-460.

Online-Interventionen (PE-Block 1-3)

  • Shou S, Xiu S, Li Y, Zhang N, Yu J, Ding J, Wang J. Efficacy of Online Intervention for ADHD: A Meta-Analysis and Systematic Review. Front Psychol. 2022 Jun 28;13:854810.

Organisation (PE-Block 1-10, 3-4, 4-4, 6-4, 7-4)

  • Langberg JM, Epstein JN, Graham AJ. Organizational-skills interventions in the treatment of ADHD. Expert Rev Neurother. 2008 Oct;8(10):1549-61.

Persistenz von Kindheit ins Erwachsenenalter (PE-Block 1-3)

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • Di Lorenzo R, et al. Children and adolescents with ADHD followed up to adulthood: a systematic review of long-term outcomes. Acta Neuropsychiatr. 2021 Dec;33(6):283-298.

  • Caye A, et al. Predictors of persistence of ADHD into adulthood: a systematic review of the literature and meta-analysis. Eur Child Adolesc Psychiatry. 2016 Nov;25(11):1151-1159.

  • Sibley MH, et al. MTA Cooperative Group. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2017 Jun;58(6):655-662.

Pharmakotherapie, Medikamente, Stimulanzien (PE-Block 1-3, 1-7, 1-8, 3-2, 3-3, )

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • Faraone SV, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev 2021; 128: 789-818.

  • May T, et al. The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2023 Aug;57(8):1101-1116.

  • Kooij JJS, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019 Feb;56:14-34.

  • Cortese S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018 Sep;5(9):727-738.

  • Elliott J, et al. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLoS One. 2020 Oct 21;15(10):e0240584.

  • Gajria K, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review. Neuropsychiatr Dis Treat. 2014 Aug 22;10:1543-69.

  • Lenzi F, et al. Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2018 Jan;84:359-367.

  • Radonjić NV, et al. Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis. CNS Drugs. 2023 May;37(5):381-397.

Prokrastination (PE-Block 9-1, 9-2)

  • Müller V, Mellor D, Piko BF. How to Procrastinate Productively With ADHD: A Study of Smartphone Use, Depression, and Other Academic Variables Among University Students With ADHD Symptoms. J Atten Disord. 2023 Jul;27(9):951-959.

Risikoverhalten (PE-Block 1-3, 1-7, 5-5)

  • Brunkhorst-Kanaan N, et al. ADHD and accidents over the life span – A systematic review. Neurosci Biobehav Rev. 2021 Jun;125:582-591.

Schlaf (PE-Block 11-3, 11-4)

  • Becker SP. ADHD and sleep: recent advances and future directions. Curr Opin Psychol. 2020 Aug;34:50-56.

  • Lugo J, et al. Sleep in adults with autism spectrum disorder and attention deficit/hyperactivity disorder: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2020 Sep;38:1-24.

  • Wajszilber D, et al. Sleep disorders in patients with ADHD: impact and management challenges. Nat Sci Sleep. 2018 Dec 14;10:453-480.

Selbstwert (PE-Block 10-1)

  • Cook J, et al. The self-esteem of adults diagnosed with attention-deficit/hyperactivity disorder (ADHD): a systematic review of the literature. Atten Defic Hyperact Disord. 2014 Dec;6(4):249-68.

Selbsthilfestrategien (PE-Block 1-10, 2-5, 3-4, 4-4, 5-6, 6-4, 7-4, 8-5, 9-2, 10-5, 11-4, 12-2)

  • Becker P, et al. Selfcare Strategies Shown to Be Useful in Daily Life for Adults Diagnosed with Attention Deficit Hyperactivity Disorder – A Systematic Review. Issues Ment Health Nurs. 2023 Sep;44(9):825-833.

Sport (PE-Block 1-8, 4-2)

  • MacLean L, et al. Attention-Deficit/Hyperactivity Disorder and Sports: A Lifespan Perspective. Psychiatr Clin North Am. 2021 Sep;44(3):419-430.

  • Weibel S, et al. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Encephale. 2020 Feb;46(1):30-40.

Stress (PE-Block 11-1, 11-2)

  • Lee EH. Review of the psychometric evidence of the perceived stress scale. Asian Nurs Res (Korean Soc Nurs Sci) 2012; 6: 121-7.

Symptome (PE-Block 1-3, 2-1, 3-1, 4-1, 5-1, 6-1, 7-1, 8-1)

  • CADDRA – Canadian ADHD Resource Alliance: Canadian ADHD Practice Guidelines, 4.1 Edition, Toronto ON; CADDRA, 2020.

  • 2nd S3 guideline ADHD in children, adolescents and adults. DGPPN, German Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP), German Society for Social Pediatrics and Adolescent Medicine e. V. (DGSPJ), 2018.

  • Faraone SV, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev 2021; 128: 789-818.

  • May T, et al. The Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder. Aust N Z J Psychiatry. 2023 Aug;57(8):1101-1116.

  • Kooij JJS, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019 Feb;56:14-34.

  • Schneider BC, et al. Assessment of Adult ADHD in Clinical Practice: Four Letters-40 Opinions. J Atten Disord. 2023 Jul;27(9):1051-1061.

Ursachen (PE-Block 1-3, 2-2)

  • Elbagir R, et al. Systematic Review of Environmental and Psychosocial Risk Factors associated with Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder, and Conduct Disorder in Children and Adolescents. Scand J Child Adolesc Psychiatr Psychol. 2023 Aug 25;11(1):108-119.

  • Pagán AF, et al. Adult Attention-Deficit/Hyperactivity Disorder: a Narrative Review of Biological Mechanisms, Treatments, and Outcomes. Curr Neurol Neurosci Rep. 2023 Aug;23(8):451-460.

Funktionalität „Medikamententool“

Auswahlmöglichkeit von in Deutschland zugelassenen ADHS-Medikamenten für Erwachsene mit ADHS aus dem Arzneimittelverzeichnis der Gelben Liste https://www.gelbe-liste.de/ mit mehreren Bewertungen verschiedener Experten.
 
Funktionalität „Therapietagebuch”

  • Brod M, et al. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA. Atten Defic Hyperact Disord. 2015; 7: 141-50.

  • Kessler RC, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005; 35: 245-56.

  • Adler LA, et al. Validity of pilot Adult ADHD Self-Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry 2006; 18: 145-8.

  • Dobrosavljevic M, et al. The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults. Expert Rev Neurother. 2023 Jul-Dec;23(10):883-893.

  • Ramsay JR. Assessment and monitoring of treatment response in adult ADHD patients: current perspectives. Neuropsychiatr Dis Treat. 2017 Jan 27;13:221-232.

Weitere Quellen

  • Bueno V.F. et al., Mindfulness Meditation Improves Mood, Quality of Life, and Attention in Adults with Attention Deficit Hyperactivity Disorder. Biomed Res Int. 2015;2015:962857. doi: 10.1155/2015/962857. Epub 2015 Jun 7. PMID: 26137496; PMCID: PMC4475526.

  • Corrales M. et al., Long-term efficacy of a new 6-session cognitive behavioral therapy for adults with attention-deficit/hyperactivity disorder: A randomized, controlled clinical trial; Psychiatry Res;2024;10.1016/j.psychres.2023.115642

  • Halmøy A. et al., Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: a multicenter randomized controlled trial; BMC Psychiatry;2022;10.1186/s12888-022-04356-6

  • Hanssen K.T. et al., Improvement of anxiety in ADHD following goal-focused cognitive remediation: a randomized controlled trial;Front Psychol;2023;10.3389/fpsyg.2023.1212502.

  • Kenter R.M.F et al., A self-guided internet-delivered intervention for adults with ADHD: Results from a randomized controlled trial; Internet Interv;2023;10.1016/j.invent.2023.100614.

  • Guo C. et al., Efficacy of Non-pharmacological Treatments on Emotional Symptoms of Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis. J Atten Disord. 2022 Feb;26(4):508-524. doi: 10.1177/10870547211001953. Epub 2021 Mar 24. PMID: 33759605.

  • Nasri B et al., Internet delivered cognitive behavioral therapy for adults with ADHD – A randomized controlled trial, Internet Interventions, Volume 33, 2023, 100636, ISSN 2214-7829, https://doi.org/10.1016/ j.invent.2023.100636.

  • NICE guideline Attention deficit hyperactivity disorder: diagnosis and management, 2018

  • Stern P. et al., Near and Far Transfer Effects of Computerized Progressive Attention Training (CPAT) Versus Mindfulness Based Stress Reduction (MBSR) Practice Among Adults With ADHD;J Atten Disord;2023;10.1177/ 1087054723115587.

  • Tan B.L. et al., Medalia A. The use of virtual reality and augmented reality in psychosocial rehabilitation for adults with neurodevelopmental disorders: A systematic review. 

C-APROM/DE/NS/0126